Insights
Search Results
Client Highlights
7.13.26
Wilson Sonsini Advises Oratomic on $300 Million Series A Financing
On July 7, 2026, Oratomic, a neutral atom quantum computing company focused on building the world’s first fault-tolerant quantum computers, announced that it raised $300 million in its Series A round co-led by ARCH Venture Partners, Spark Capital, and Khosla Ventures, alongside Bezos Expeditions, Index Ventures, General Catalyst, Lowercarbon Capital, Bain Capital, Formation, Nebular, David and Scott Aaronson, and others. Wilson Sonsini Goodrich & Rosati advised Oratomic on the transaction.
Client Highlights
6.18.26
Wilson Sonsini Advises SandboxAQ on Agreement with the U.S. Department of Commerce for $500 Million CHIPS R&D Award
On June 17, 2026, SandboxAQ announced a definitive agreement with the U.S. Department of Commerce's CHIPS Research and Development Office for a $500 million award to address one of the most urgent challenges in American manufacturing: the foreign control of critical materials and chemistries that are essential to semiconductor manufacturing. Wilson Sonsini Goodrich & Rosati advised SandboxAQ on the transaction.
Client Highlights
6.03.26
Wilson Sonsini Advises Isomorphic Labs on $2.1 Billion Series B Investment Round
On May 12, 2026, Isomorphic Labs, an AI-first drug design and development company, announced it has raised $2.1 billion in Series B funding. The financing round is led by Thrive Capital, and includes participation from existing backers Alphabet and GV alongside new investors MGX, Temasek, CapitalG, and the UK Sovereign AI Fund, significantly expanding Isomorphic Labs’ global capital base. Wilson Sonsini Goodrich & Rosati advised Isomorphic Labs on the transaction.
Newsletters
3.16.26
2025 Technology and Life Sciences IPO Report
Wilson Sonsini’s 2025 Technology and Life Sciences IPO Report provides in-depth analysis on 40 initial public offerings (IPOs) and five direct listings completed by U.S.-based technology and life sciences companies in 2025 with deal values exceeding $75 million.
Client Highlights
9.22.25
Wilson Sonsini Advises Netskope on IPO
On September 17, 2025, Netskope, a leader in modern security and networking for the cloud and AI era, announced the pricing of its initial public offering of 47,800,000 shares of its Class A common stock at a public offering price of $19.00 per share. The shares began trading on the Nasdaq Global Select Market on September 18, 2025, under the ticker symbol “NTSK.” The offering closed on September 19, 2025. Additionally, on September 22, 2025, Netskope announced the full exercise of its over-allotment option of 7,170,000 shares of Class A common stock. Wilson Sonsini Goodrich & Rosati advised Netskope on the transaction.
Client Highlights
7.21.25
Wilson Sonsini Advises Cloudflare on $2.0 Billion Convertible Senior Notes
On June 17, 2025, Cloudflare, Inc. issued $2.0 billion aggregate principal amount of 0% Convertible Senior Notes due 2030. The offering amount included the exercise in full of the option that Cloudflare had granted to the initial purchasers to purchase up to an additional $250 million of notes. In connection with the offering, Cloudflare entered into privately negotiated capped call transactions with certain of the initial purchasers or their respective affiliates and other financial institutions.
Client Highlights
4.07.25
Wilson Sonsini Advises Isomorphic Labs on $600 Million External Funding Round
On March 31, 2025, Isomorphic Labs, an AI-first drug design and development company, announced it has raised $600 million in its first external funding round led by Thrive Capital, with participation from GV, and follow-on capital from existing investor Alphabet. Wilson Sonsini Goodrich & Rosati advised Isomorphic Labs on the transaction.
Newsletters
2.27.25
2024 Technology and Life Sciences IPO Report
Wilson Sonsini's 2024 Technology and Life Sciences IPO Report provides in-depth analysis on 33 initial public offerings (IPOs) completed by U.S.-based technology and life sciences companies in 2024 with deal values exceeding $75 million. Despite a lower overall IPO activity compared to the pandemic-era boom, 2024 witnessed a significant increase in deal volume, indicating a growing traction in the IPO market as macroeconomic conditions stabilized.
Client Highlights
12.13.24
Wilson Sonsini Advises Dropbox on $2 Billion Secured Credit Facility
On December 11, 2024, Dropbox announced that it entered into a Credit and Guaranty Agreement for a secured term loan facility in an aggregate principal amount of up to $2 billion, consisting of initial term loans in an aggregate principal amount of up to $1.0 billion and delayed draw term loans in an aggregate principal amount of up to $1.0 billion. The facility was led and substantially provided by Blackstone Credit & Insurance, who served as lead arranger and lead structuring agent. The proceeds of the term loans may be used for working capital and general corporate purposes, including share repurchases.
Client Highlights
12.09.24
Wilson Sonsini Advises Lightsynq on $18 Million Series A
On November 19, 2024, Lightsynq Technologies, a start-up developing quantum interconnect technology solutions for commercial use, emerged from stealth and announced a successful raise of $18 million in Series A funding. The round was led by Cerberus Ventures, the venture investing platform of Cerberus Capital Management, with participation from Murata Electronics North America, IAG Capital Partners, Safar Partners, QVT, Element Six, and In-Q-Tel. Wilson Sonsini Goodrich & Rosati advised Lightsynq on the transaction.
Client Highlights
6.05.24
Wilson Sonsini Advises BlackLine on Private Offering of $675 Million Convertible Senior Notes
On May 24, 2024, BlackLine, a leading provider of cloud software that automates and controls financial close and accounting processes, announced an upsized convertible senior note private offering of $600 million due 2029. On June 4, 2024, the initial purchasers of the notes exercised their option to purchase an additional $75 million of the convertible senior notes. Wilson Sonsini Goodrich & Rosati represented BlackLine on the transaction.
Newsletters
3.28.24
2023 Technology and Life Sciences IPO Report
Market volatility, high interest rates, and ongoing geopolitical conflict continue to influence low levels of IPO activity in the U.S. capital markets. The trend is observed across all sectors, resulting in IPO levels similar to those seen during and in the aftermath of the 2009 financial crisis. While the third quarter of 2023 saw a boost with a handful of high-profile technology companies completing their IPOs, it did not usher in a wave of other transactions. Many companies continue to opt for a “wait-and-see” approach.